A Study to Assess the Effect of Povorcitinib on Digoxin, Rosuvastatin, and Metformin Pharmacokinetics When Administered Orally to Healthy Adult Participants - Trial NCT06416800
Access comprehensive clinical trial information for NCT06416800 through Pure Global AI's free database. This Phase 1 trial is sponsored by Incyte Corporation and is currently Not yet recruiting. The study focuses on Healthy Participants. Target enrollment is 54 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Incyte Corporation
Timeline & Enrollment
Phase 1
Jun 19, 2024
Aug 10, 2024
Primary Outcome
Pharmacokinetic (PK) in plasma digoxin,PK in plasma rosuvastatin,PK in plasma metformin
Summary
The purpose of this study is to Assess the Effect of Povorcitinib on Digoxin, Rosuvastatin,
 and Metformin Pharmacokinetics When Administered Orally to Healthy Adult Participants.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06416800
Non-Device Trial